{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:57:21Z","timestamp":1792112241295,"version":"4.4.0"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T00:00:00Z","timestamp":1484784000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s40262-017-0507-7","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T16:28:04Z","timestamp":1484843284000},"page":"893-913","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1048,"title":["Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine"],"prefix":"10.1007","volume":"56","author":[{"given":"Maud A. S.","family":"Weerink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel M. R. F.","family":"Struys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura N.","family":"Hannivoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens R. M.","family":"Barends","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"Absalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Colin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,19]]},"reference":[{"key":"507_CR1","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00000542-199212000-00013","volume":"77","author":"JP Belleville","year":"1992","unstructured":"Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology. 1992;77:1125\u201333.","journal-title":"Anesthesiology"},{"key":"507_CR2","unstructured":"US Food and Drug Administration. Precedex label. 1999. Available from: \n                        http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/1999\/21038lbl.pdf\n                        \n                    . Accessed 14 Nov 2016."},{"key":"507_CR3","unstructured":"European Medicines Agency. European Public Assessment Report. 2016. Available from: \n                        http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002268\/WC500115631.pdf\n                        \n                    . Accessed 14 Nov 2016."},{"key":"507_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(88)90744-3","volume":"150","author":"R Virtanen","year":"1988","unstructured":"Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol. 1988;150:9\u201314.","journal-title":"Eur J Pharmacol"},{"key":"507_CR5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00000542-199108000-00013","volume":"75","author":"TZ Guo","year":"1991","unstructured":"Guo TZ, Tinklenberg J, Oliker R, Maze M. Central alpha 1-adrenoceptor stimulation functionally antagonizes the hypnotic response to dexmedetomidine, an alpha 2-adrenoceptor agonist. Anesthesiology. 1991;75:252\u20136.","journal-title":"Anesthesiology"},{"key":"507_CR6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00000539-200003000-00035","volume":"90","author":"JE Hall","year":"2000","unstructured":"Hall JE, Uhrich TD, Barney JA, et al. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000;90:699\u2013705.","journal-title":"Anesth Analg"},{"key":"507_CR7","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1093\/bja\/aew113","volume":"116","author":"FA Lobo","year":"2016","unstructured":"Lobo FA, Wagemakers M, Absalom AR. Anaesthesia for awake craniotomy. Br J Anaesth. 2016;116:740\u20134.","journal-title":"Br J Anaesth"},{"key":"507_CR8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1126\/science.273.5276.801","volume":"273","author":"LB MacMillan","year":"1996","unstructured":"MacMillan LB, Hein L, Smith MS, et al. Central hypotensive effects of the alpha2a-adrenergic receptor subtype. Science. 1996;273:801\u20133.","journal-title":"Science"},{"key":"507_CR9","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00000542-200008000-00016","volume":"93","author":"TJ Ebert","year":"2000","unstructured":"Ebert TJ, Hall JE, Barney JA, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000;93:382\u201394.","journal-title":"Anesthesiology"},{"key":"507_CR10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/0971-9784.91480","volume":"15","author":"S Sulaiman","year":"2012","unstructured":"Sulaiman S, Karthekeyan RB, Vakamudi M, et al. The effects of dexmedetomidine on attenuation of stress response to endotracheal intubation in patients undergoing elective off-pump coronary artery bypass grafting. Ann Card Anaesth. 2012;15:39\u201343.","journal-title":"Ann Card Anaesth"},{"key":"507_CR11","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s00540-011-1215-3","volume":"25","author":"T Kunisawa","year":"2011","unstructured":"Kunisawa T, Ueno M, Kurosawa A, et al. Dexmedetomidine can stabilize hemodynamics and spare anesthetics before cardiopulmonary bypass. J Anesth. 2011;25:818\u201322.","journal-title":"J Anesth"},{"key":"507_CR12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/00126839-200607010-00004","volume":"7","author":"M Yildiz","year":"2006","unstructured":"Yildiz M, Tavlan A, Tuncer S, et al. Effect of dexmedetomidine on haemodynamic responses to laryngoscopy and intubation : perioperative haemodynamics and anaesthetic requirements. Drugs R D. 2006;7:43\u201352.","journal-title":"Drugs R D"},{"key":"507_CR13","volume-title":"Mendeley reference manager","author":"Mendeley Ltd.","year":"2016","unstructured":"Mendeley Ltd. Mendeley reference manager. Amsterdam: Elsevier; 2016."},{"key":"507_CR14","unstructured":"DrugBank. Dexmedetomidine. 2016. Available from: \n                        https:\/\/www.drugbank.ca\/drugs\/DB00633\n                        \n                    . Accessed 17 Nov 2016."},{"key":"507_CR15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1046\/j.1365-2125.2003.01944.x","volume":"56","author":"M Anttila","year":"2003","unstructured":"Anttila M, Penttil\u00e4 J, Helminen A, et al. Bioavailability of dexmedetomidine after extravascular doses in healthy subjects. Br J Clin Pharmacol. 2003;56:691\u20133.","journal-title":"Br J Clin Pharmacol"},{"key":"507_CR16","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00228-015-1913-0","volume":"71","author":"H Yoo","year":"2015","unstructured":"Yoo H, Iirola T, Vilo S, et al. Mechanism-based population pharmacokinetic and pharmacodynamic modeling of intravenous and intranasal dexmedetomidine in healthy subjects. Eur J Clin Pharmacol. 2015;71:1197\u2013207.","journal-title":"Eur J Clin Pharmacol"},{"key":"507_CR17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00228-011-1002-y","volume":"67","author":"T Iirola","year":"2011","unstructured":"Iirola T, Vilo S, Manner T, et al. Bioavailability of dexmedetomidine after intranasal administration. Eur J Clin Pharmacol. 2011;67:825\u201331.","journal-title":"Eur J Clin Pharmacol"},{"key":"507_CR18","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/anae.13407","volume":"71","author":"BL Li","year":"2016","unstructured":"Li BL, Zhang N, Huang JX, et al. A comparison of intranasal dexmedetomidine for sedation in children administered either by atomiser or by drops. Anaesthesia. 2016;71:522\u20138.","journal-title":"Anaesthesia"},{"key":"507_CR19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/bean.2000.0081","volume":"14","author":"MD Karol","year":"2000","unstructured":"Karol MD, Maze M. Pharmacokinetics and interaction pharmacodynamics of dexmedetomidine in humans. Best Pract Res Clin Anaesthesiol. 2000;14:261\u20139.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"507_CR20","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00000539-200111000-00031","volume":"93","author":"AM Wolf De","year":"2001","unstructured":"De Wolf AM, Fragen RJ, Avram MJ, et al. The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment. Anesth Analg. 2001;93:1205\u20139.","journal-title":"Anesth Analg"},{"key":"507_CR21","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/00000542-199305000-00002","volume":"78","author":"JB Dyck","year":"1993","unstructured":"Dyck JB, Maze M, Haack C, et al. The pharmacokinetics and hemodynamic effects of intravenous and intramuscular dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology. 1993;78:813\u201320.","journal-title":"Anesthesiology"},{"key":"507_CR22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/bja\/88.5.669","volume":"88","author":"RM Venn","year":"2002","unstructured":"Venn RM, Karol MD, Grounds RM. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care. Br J Anaesth. 2002;88:669\u201375.","journal-title":"Br J Anaesth"},{"key":"507_CR23","doi-asserted-by":"crossref","first-page":"R257","DOI":"10.1186\/cc10518","volume":"15","author":"T Iirola","year":"2011","unstructured":"Iirola T, Aantaa R, Laitio R, et al. Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients. Crit Care. 2011;15:R257.","journal-title":"Crit Care"},{"key":"507_CR24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s40261-013-0101-1","volume":"33","author":"PA V\u00e4litalo","year":"2013","unstructured":"V\u00e4litalo PA, Ahtola-S\u00e4til\u00e4 T, Wighton A, et al. Population pharmacokinetics of dexmedetomidine in critically ill patients. Clin Drug Invest. 2013;33:579\u201387.","journal-title":"Clin Drug Invest"},{"key":"507_CR25","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jclinane.2015.06.002","volume":"27","author":"T Zhang","year":"2015","unstructured":"Zhang T, Deng Y, He P, et al. Effects of mild hypoalbuminemia on the pharmacokinetics and pharmacodynamics of dexmedetomidine in patients after major abdominal or thoracic surgery. J Clin Anesth. 2015;27:632\u20137.","journal-title":"J Clin Anesth"},{"key":"507_CR26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/(SICI)1520-6017(200004)89:4<519::AID-JPS9>3.0.CO;2-U","volume":"89","author":"S Dutta","year":"2000","unstructured":"Dutta S, Lal R, Karol MD, et al. Influence of cardiac output on dexmedetomidine pharmacokinetics. J Pharm Sci. 2000;89:519\u201327.","journal-title":"J Pharm Sci"},{"key":"507_CR27","first-page":"651","volume":"25","author":"AD Rodrigues","year":"1997","unstructured":"Rodrigues AD, Roberts EM. The in vitro interaction of dexmedetomidine with human liver microsomal cytochrome P4502D6 (CYP2D6). Drug Metab Dispos. 1997;25:651\u20135.","journal-title":"Drug Metab Dispos"},{"key":"507_CR28","unstructured":"Abbott Laboratories. Precedex approval documents. 2001. Available from: \n                        http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/99\/21-038_Precedex.cfm\n                        \n                    . Accessed 15 Nov 2016."},{"key":"507_CR29","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2710.2012.01357.x","volume":"37","author":"S Lee","year":"2012","unstructured":"Lee S, Kim B-H, Lim K, et al. Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects. J Clin Pharm Ther. 2012;37:698\u2013703.","journal-title":"J Clin Pharm Ther"},{"key":"507_CR30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF00194403","volume":"46","author":"KT Kivist\u00f6","year":"1994","unstructured":"Kivist\u00f6 KT, Kallio A, Neuvonen PJ. Pharmacokinetics and pharmacodynamics of transdermal dexmedetomidine. Eur J Clin Pharmacol. 1994;46:345\u20139.","journal-title":"Eur J Clin Pharmacol"},{"key":"507_CR31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1067\/mcp.2002.121829","volume":"71","author":"L Benet","year":"2002","unstructured":"Benet L. Changes in plasma protein binding have little clinical relevance. Clin Pharmacol Ther. 2002;71:115\u201321.","journal-title":"Clin Pharmacol Ther"},{"key":"507_CR32","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/bja\/aer441","volume":"108","author":"T Iirola","year":"2012","unstructured":"Iirola T, Ihmsen H, Laitio R, et al. Population pharmacokinetics of dexmedetomidine during long-term sedation in intensive care patients. Br J Anaesth. 2012;108:460\u20138.","journal-title":"Br J Anaesth"},{"key":"507_CR33","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1021\/js9702168","volume":"86","author":"JA Johnson","year":"1997","unstructured":"Johnson JA. Influence of race or ethnicity on pharmacokinetics of drugs. J Pharm Sci. 1997;86:1328\u201333.","journal-title":"J Pharm Sci"},{"key":"507_CR34","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3810\/hp.2012.02.959","volume":"40","author":"BR Tellor","year":"2012","unstructured":"Tellor BR, Arnold HM, Micek ST, Kollef MH. Occurrence and predictors of dexmedetomidine infusion intolerance and failure. Hosp Pract. 2012;40:186\u201392.","journal-title":"Hosp Pract"},{"key":"507_CR35","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/HYPERTENSIONAHA.107.098939","volume":"51","author":"D Kurnik","year":"2008","unstructured":"Kurnik D, Muszkat M, Sofowora GG, et al. Ethnic and genetic determinants of cardiovascular response to the selective 2-adrenoceptor agonist dexmedetomidine. Hypertension. 2008;51:406\u201311.","journal-title":"Hypertension"},{"key":"507_CR36","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00228-011-1208-z","volume":"68","author":"U Kohli","year":"2012","unstructured":"Kohli U, Pandharipande P, Muszkat M, et al. CYP2A6 genetic variation and dexmedetomidine disposition. Eur J Clin Pharmacol. 2012;68:937\u201342.","journal-title":"Eur J Clin Pharmacol"},{"key":"507_CR37","doi-asserted-by":"crossref","first-page":"805013","DOI":"10.1155\/2014\/805013","volume":"2014","author":"SF Holliday","year":"2014","unstructured":"Holliday SF, Kane-Gill SL, Empey PE, et al. Interpatient variability in dexmedetomidine response: a survey of the literature. Sci World J. 2014;2014:805013.","journal-title":"Sci World J"},{"key":"507_CR38","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1213\/00000539-199711000-00033","volume":"85","author":"P Talke","year":"1997","unstructured":"Talke P, Richardson CA, Scheinin M, Fisher DM. Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg. 1997;85:1136\u201342.","journal-title":"Anesth Analg"},{"key":"507_CR39","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1399-6576.2010.02392.x","volume":"55","author":"L Lin","year":"2011","unstructured":"Lin L, Guo X, Zhang M-Z, et al. Pharmacokinetics of dexmedetomidine in Chinese post-surgical intensive care unit patients. Acta Anaesthesiol Scand. 2011;55:359\u201367.","journal-title":"Acta Anaesthesiol Scand"},{"key":"507_CR40","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00228-015-1948-2","volume":"71","author":"LI Cort\u00ednez","year":"2015","unstructured":"Cort\u00ednez LI, Anderson BJ, Holford NHG, et al. Dexmedetomidine pharmacokinetics in the obese. Eur J Clin Pharmacol. 2015;71:1501\u20138.","journal-title":"Eur J Clin Pharmacol"},{"key":"507_CR41","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5414\/CP202521","volume":"54","author":"Y Kuang","year":"2016","unstructured":"Kuang Y, Xiang Y, Guo C-X, et al. Population pharmacokinetics study of dexmedetomidine in Chinese adult patients during spinal anesthesia. Int J Clin Pharmacol Ther. 2016;54:200\u20137.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"507_CR42","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/ALN.0000000000000740","volume":"123","author":"LN Hannivoort","year":"2015","unstructured":"Hannivoort LN, Eleveld DJ, Proost JH, et al. Development of an optimized pharmacokinetic model of dexmedetomidine using target-controlled infusion in healthy volunteers. Anesthesiology. 2015;123:357\u201367.","journal-title":"Anesthesiology"},{"key":"507_CR43","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1460-9592.2009.03133.x","volume":"19","author":"AL Potts","year":"2009","unstructured":"Potts AL, Anderson BJ, Warman GR, et al. Dexmedetomidine pharmacokinetics in pediatric intensive care: a pooled analysis. Paediatr Anaesth. 2009;19:1119\u201329.","journal-title":"Paediatr Anaesth"},{"key":"507_CR44","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10928-016-9474-0","volume":"43","author":"P Wiczling","year":"2016","unstructured":"Wiczling P, Bartkowska-\u015aniatkowska A, Szerkus O, et al. The pharmacokinetics of dexmedetomidine during long-term infusion in critically ill pediatric patients: a Bayesian approach with informative priors. J Pharmacokinet Pharmacodyn. 2016;43:315\u201324.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"507_CR45","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1213\/ANE.0000000000000869","volume":"122","author":"F Su","year":"2016","unstructured":"Su F, Gastonguay MR, Nicolson SC, et al. Dexmedetomidine pharmacology in neonates and infants after open heart surgery. Anesth Analg. 2016;122:1556\u201366.","journal-title":"Anesth Analg"},{"key":"507_CR46","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1213\/ANE.0b013e3181d783c8","volume":"110","author":"F Su","year":"2010","unstructured":"Su F, Nicolson SC, Gastonguay MR, et al. Population pharmacokinetics of dexmedetomidine in infants after open heart surgery. Anesth Analg. 2010;110:1383\u201392.","journal-title":"Anesth Analg"},{"key":"507_CR47","doi-asserted-by":"publisher","DOI":"10.1007\/s13318-016-0333-6","author":"H-C Liu","year":"2016","unstructured":"Liu H-C, Lian Q-Q, Wu F-F, et al. Population pharmacokinetics of dexmedetomidine after short intravenous infusion in Chinese children. Eur J Drug Metab Pharmacokinet. 2016. doi:\n                        10.1007\/s13318-016-0333-6\n                        \n                    .","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"507_CR48","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1213\/ANE.0000000000000165","volume":"118","author":"DJ Eleveld","year":"2014","unstructured":"Eleveld DJ, Proost JH, Cort\u00ednez LI, et al. A general purpose pharmacokinetic model for propofol. Anesth Analg. 2014;118:1221\u201337.","journal-title":"Anesth Analg"},{"key":"507_CR49","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00000542-200302000-00024","volume":"98","author":"LE Nelson","year":"2003","unstructured":"Nelson LE, Lu J, Guo T, et al. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology. 2003;98:428\u201336.","journal-title":"Anesthesiology"},{"key":"507_CR50","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nn.3957","volume":"18","author":"Z Zhang","year":"2015","unstructured":"Zhang Z, Ferretti V, G\u00fcntan \u0130, et al. Neuronal ensembles sufficient for recovery sleep and the sedative actions of \u03b12 adrenergic agonists. Nat Neurosci. 2015;18:553\u201361.","journal-title":"Nat Neurosci"},{"key":"507_CR51","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00000542-198812000-00004","volume":"69","author":"IS Segal","year":"1988","unstructured":"Segal IS, Vickery RG, Walton JK, et al. Dexmedetomidine diminishes halothane anesthetic requirements in rats through a postsynaptic alpha 2 adrenergic receptor. Anesthesiology. 1988;69:818\u201323.","journal-title":"Anesthesiology"},{"key":"507_CR52","first-page":"854","volume-title":"Miller\u2019s anesthesia","author":"J Vuyk","year":"2015","unstructured":"Vuyk J, Sitsen E, Reekers M. Intravenous anesthetics. In: Miller RD, Cohen NH, Eriksson LI, et al., editors. Miller\u2019s anesthesia. 8th ed. Amsterdam: Elsevier; 2015. p. 854\u20139.","edition":"8"},{"key":"507_CR53","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/00000542-200409000-00024","volume":"101","author":"MS Angst","year":"2004","unstructured":"Angst MS, Ramaswamy B, Davies MF, Maze M. Comparative analgesic and mental effects of increasing plasma concentrations of dexmedetomidine and alfentanil in humans. Anesthesiology. 2004;101:744\u201352.","journal-title":"Anesthesiology"},{"key":"507_CR54","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00000542-198907000-00014","volume":"71","author":"VA Doze","year":"1989","unstructured":"Doze VA, Chen BX, Maze M. Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors. Anesthesiology. 1989;71:75\u20139.","journal-title":"Anesthesiology"},{"key":"507_CR55","first-page":"61","volume":"85","author":"V Doze","year":"1989","unstructured":"Doze V, Chen BX, Li Z, Maze M. Pharmacologic characterization of the receptor mediating the hypnotic action of dexmedetomidine. Acta Vet Scand Suppl. 1989;85:61\u20134.","journal-title":"Acta Vet Scand Suppl"},{"key":"507_CR56","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/00000542-199206000-00013","volume":"76","author":"C Correa-Sales","year":"1992","unstructured":"Correa-Sales C, Rabin BC, Maze M. A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats. Anesthesiology. 1992;76:948\u201352.","journal-title":"Anesthesiology"},{"key":"507_CR57","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1097\/00000542-199212000-00014","volume":"77","author":"BC Bloor","year":"1992","unstructured":"Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology. 1992;77:1134\u201342.","journal-title":"Anesthesiology"},{"key":"507_CR58","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/jama.2009.56","volume":"301","author":"RR Riker","year":"2009","unstructured":"Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients; a randomized trial. JAMA. 2009;301:489.","journal-title":"JAMA"},{"key":"507_CR59","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2012.304","volume":"307","author":"SM Jakob","year":"2012","unstructured":"Jakob SM. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation. JAMA. 2012;307:1151.","journal-title":"JAMA"},{"key":"507_CR60","first-page":"CD010269","volume":"1","author":"K Chen","year":"2015","unstructured":"Chen K, Lu Z, Xin YC, et al. Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients. Cochrane Database Syst Rev. 2015;1:CD010269.","journal-title":"Cochrane Database Syst Rev"},{"key":"507_CR61","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1176\/appi.psy.50.3.206","volume":"50","author":"JR Maldonado","year":"2009","unstructured":"Maldonado JR, Wysong A, van der Starre PJA, et al. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics. 2009;50:206\u201317.","journal-title":"Psychosomatics"},{"key":"507_CR62","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1001\/jama.298.22.2644","volume":"298","author":"PP Pandharipande","year":"2007","unstructured":"Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients. JAMA. 2007;298:2644.","journal-title":"JAMA"},{"key":"507_CR63","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1540-8191.2012.01472.x","volume":"27","author":"Y Lin","year":"2012","unstructured":"Lin Y, Chen J, Wang Z. Meta-analysis of factors which influence delirium following cardiac surgery. J Card Surg. 2012;27:481\u201392.","journal-title":"J Card Surg"},{"key":"507_CR64","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1213\/ane.0b013e3181ae0856","volume":"110","author":"KA Candiotti","year":"2010","unstructured":"Candiotti KA, Bergese SD, Bokesch PM, et al. Monitored anesthesia care with dexmedetomidine: a prospective, randomized, double-blind, multicenter trial. Anesth Analg. 2010;110:47\u201356.","journal-title":"Anesth Analg"},{"key":"507_CR65","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/MJT.0b013e3181d69072","volume":"17","author":"SD Bergese","year":"2010","unstructured":"Bergese SD, Candiotti KA, Bokesch PM, et al. A phase IIIb, randomized, double-blind, placebo-controlled, multicenter study evaluating the safety and efficacy of dexmedetomidine for sedation during awake fiberoptic intubation. Am J Ther. 2010;17:586\u201395.","journal-title":"Am J Ther"},{"key":"507_CR66","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/ANA.0b013e318060d281","volume":"19","author":"P Talke","year":"2007","unstructured":"Talke P, Stapelfeldt C, Garcia P. Dexmedetomidine does not reduce epileptiform discharges in adults with epilepsy. J Neurosurg Anesthesiol. 2007;19:195\u20139.","journal-title":"J Neurosurg Anesthesiol"},{"key":"507_CR67","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1345\/aph.1M310","volume":"43","author":"AT Gerlach","year":"2009","unstructured":"Gerlach AT, Murphy CV, Dasta JF. An updated focused review of dexmedetomidine in adults. Ann Pharmacother. 2009;43:2064\u201374.","journal-title":"Ann Pharmacother"},{"key":"507_CR68","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00000542-199101000-00002","volume":"74","author":"T Kauppila","year":"1991","unstructured":"Kauppila T, Kemppainen P, Tanila H, Pertovaara A. Effect of systemic medetomidine, an alpha 2 adrenoceptor agonist, on experimental pain in humans. Anesthesiology. 1991;74:3\u20138.","journal-title":"Anesthesiology"},{"key":"507_CR69","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00000542-200307000-00014","volume":"99","author":"P Talke","year":"2003","unstructured":"Talke P, Lobo E, Brown R. Systemically administered alpha2-agonist-induced peripheral vasoconstriction in humans. Anesthesiology. 2003;99:65\u201370.","journal-title":"Anesthesiology"},{"key":"507_CR70","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/sj.bjp.0704320","volume":"134","author":"XF Figueroa","year":"2001","unstructured":"Figueroa XF, Poblete MI, Boric MP, et al. Clonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoceptor activation. Br J Pharmacol. 2001;134:957\u201368.","journal-title":"Br J Pharmacol"},{"key":"507_CR71","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/anae.13084","volume":"70","author":"SH Lee","year":"2015","unstructured":"Lee SH, Choi YS, Hong GR, Oh YJ. Echocardiographic evaluation of the effects of dexmedetomidine on cardiac function during total intravenous anaesthesia. Anaesthesia. 2015;70:1052\u20139.","journal-title":"Anaesthesia"},{"key":"507_CR72","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/00000542-200411000-00005","volume":"101","author":"Y-W Hsu","year":"2004","unstructured":"Hsu Y-W, Cortinez LI, Robertson KM, et al. Dexmedetomidine pharmacodynamics: part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology. 2004;101:1066\u201376.","journal-title":"Anesthesiology"},{"key":"507_CR73","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/ALN.0000000000001236","volume":"125","author":"\u00c5 Lodenius","year":"2016","unstructured":"Lodenius \u00c5, Ebberyd A, H\u00e5rdemark Cedborg A, et al. Sedation with dexmedetomidine or propofol impairs hypoxic control of breathing in healthy male volunteers: a nonblinded, randomized crossover study. Anesthesiology. 2016;125:700\u201315.","journal-title":"Anesthesiology"},{"key":"507_CR74","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1172\/JCI107363","volume":"52","author":"RS Kronenberg","year":"1973","unstructured":"Kronenberg RS, Drage CW. Attenuation of the ventilatory and heart rate responses to hypoxia and hypercapnia with aging in normal men. J Clin Invest. 1973;52:1812\u20139.","journal-title":"J Clin Invest"},{"key":"507_CR75","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/bja\/aei263","volume":"95","author":"AM-H Ho","year":"2005","unstructured":"Ho AM-H. Central apnoea after balanced general anaesthesia that included dexmedetomidine. Br J Anaesth. 2005;95:773\u20135.","journal-title":"Br J Anaesth"},{"key":"507_CR76","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/petr.12618","volume":"20","author":"SR Stiehl","year":"2016","unstructured":"Stiehl SR, Squires JE, Bucuvalas JC, Hemmelgarn TS. Tacrolimus interaction with dexmedetomidine\u2014a case report. Pediatr Transpl. 2016;20:155\u20137.","journal-title":"Pediatr Transpl"},{"key":"507_CR77","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/ALN.0000000000000141","volume":"120","author":"AM Flexman","year":"2014","unstructured":"Flexman AM, Wong H, Riggs KW, et al. Enzyme-inducing anticonvulsants increase plasma clearance of dexmedetomidine: a pharmacokinetic and pharmacodynamic study. Anesthesiology. 2014;120:1118\u201325.","journal-title":"Anesthesiology"},{"key":"507_CR78","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4037\/ajcc2014678","volume":"23","author":"PL Smithburger","year":"2014","unstructured":"Smithburger PL, Smith RB, Kane-Gill SL, Empey PE. Patient predictors of dexmedetomidine effectiveness for sedation in intensive care units. Am J Crit Care. 2014;23:160\u20135.","journal-title":"Am J Crit Care"},{"key":"507_CR79","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-2044.1997.169-az0303.x","volume":"52","author":"CJ Lawrence","year":"1997","unstructured":"Lawrence CJ, De Lange S. Effects of a single pre-operative dexmedetomidine dose on isoflurane requirements and peri-operative haemodynamic stability. Anaesthesia. 1997;52:736\u201344.","journal-title":"Anaesthesia"},{"key":"507_CR80","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/00000542-199106000-00005","volume":"74","author":"M Aho","year":"1991","unstructured":"Aho M, Lehtinen AM, Erkola O, et al. The effect of intravenously administered dexmedetomidine on perioperative hemodynamics and isoflurane requirements in patients undergoing abdominal hysterectomy. Anesthesiology. 1991;74:997\u20131002.","journal-title":"Anesthesiology"},{"key":"507_CR81","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/00000542-199705000-00008","volume":"86","author":"R Aantaa","year":"1997","unstructured":"Aantaa R, Jaakola ML, Kallio A, Kanto J. Reduction of the minimum alveolar concentration of isoflurane by dexmedetomidine. Anesthesiology. 1997;86:1055\u201360.","journal-title":"Anesthesiology"},{"key":"507_CR82","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/pan.12358","volume":"24","author":"JR Savla","year":"2014","unstructured":"Savla JR, Ghai B, Bansal D, Wig J. Effect of intranasal dexmedetomidine or oral midazolam premedication on sevoflurane EC50 for successful laryngeal mask airway placement in children: a randomized, double-blind, placebo-controlled trial. Paediatr Anaesth. 2014;24:433\u20139.","journal-title":"Paediatr Anaesth"},{"key":"507_CR83","first-page":"301","volume":"23","author":"SS Harsoor","year":"2015","unstructured":"Harsoor SS, Rani D, Roopa MN, et al. Anesthetic sparing effect of intraoperative lignocaine or dexmedetomidine infusion on sevoflurane during general anesthesia. Middle East J Anaesthesiol. 2015;23:301\u20137.","journal-title":"Middle East J Anaesthesiol"},{"key":"507_CR84","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1046\/j.1365-2044.2001.01553.x","volume":"56","author":"CJ Peden","year":"2001","unstructured":"Peden CJ, Cloote AH, Stratford N, Prys-Roberts C. The effect of intravenous dexmedetomidine premedication on the dose requirement of propofol to induce loss of consciousness in patients receiving alfentanil. Anaesthesia. 2001;56:408\u201313.","journal-title":"Anaesthesia"},{"key":"507_CR85","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/1520-6017(200102)90:2<172::AID-JPS8>3.0.CO;2-J","volume":"90","author":"S Dutta","year":"2001","unstructured":"Dutta S, Karol MD, Cohen T, et al. Effect of dexmedetomidine on propofol requirements in healthy subjects. J Pharm Sci. 2001;90:172\u201381.","journal-title":"J Pharm Sci"},{"key":"507_CR86","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s00540-014-1949-9","volume":"29","author":"Y-E Jang","year":"2015","unstructured":"Jang Y-E, Kim Y-C, Yoon H-K, et al. A randomized controlled trial of the effect of preoperative dexmedetomidine on the half maximal effective concentration of propofol for successful i-gel insertion without muscle relaxants. J Anesth. 2015;29:338\u201345.","journal-title":"J Anesth"},{"key":"507_CR87","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1399-6576.1991.tb03290.x","volume":"35","author":"R Aantaa","year":"1991","unstructured":"Aantaa R, Kanto J, Scheinin M. Intramuscular dexmedetomidine, a novel alpha 2-adrenoceptor agonist, as premedication for minor gynaecological surgery. Acta Anaesthesiol Scand. 1991;35:283\u20138.","journal-title":"Acta Anaesthesiol Scand"},{"key":"507_CR88","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/bja\/67.4.402","volume":"67","author":"R Aantaa","year":"1991","unstructured":"Aantaa R, Jaakola ML, Kallio A, et al. A comparison of dexmedetomidine, and alpha 2-adrenoceptor agonist, and midazolam as i.m. premedication for minor gynaecological surgery. Br J Anaesth. 1991;67:402\u20139.","journal-title":"Br J Anaesth"},{"key":"507_CR89","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1399-6576.1994.tb03881.x","volume":"38","author":"ML Jaakola","year":"1994","unstructured":"Jaakola ML, Kanto J, Scheinin H, Kallio A. Intramuscular dexmedetomidine premedication: an alternative to midazolam-fentanyl-combination in elective hysterectomy? Acta Anaesthesiol Scand. 1994;38:238\u201343.","journal-title":"Acta Anaesthesiol Scand"},{"key":"507_CR90","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/00000542-199406000-00008","volume":"80","author":"M B\u00fchrer","year":"1994","unstructured":"B\u00fchrer M, Mappes A, Lauber R, et al. Dexmedetomidine decreases thiopental dose requirement and alters distribution pharmacokinetics. Anesthesiology. 1994;80:1216\u201327.","journal-title":"Anesthesiology"},{"key":"507_CR91","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/00000542-199306000-00008","volume":"78","author":"H Scheinin","year":"1993","unstructured":"Scheinin H, Jaakola ML, Sj\u00f6vall S, et al. Intramuscular dexmedetomidine as premedication for general anesthesia: a comparative multicenter study. Anesthesiology. 1993;78:1065\u201375.","journal-title":"Anesthesiology"},{"key":"507_CR92","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/ANA.0000000000000190","volume":"28","author":"J Song","year":"2016","unstructured":"Song J, Ji Q, Sun Q, et al. The opioid-sparing effect of intraoperative dexmedetomidine infusion after craniotomy. J Neurosurg Anesthesiol. 2016;28:14\u201320.","journal-title":"J Neurosurg Anesthesiol"},{"key":"507_CR93","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.clinthera.2015.02.011","volume":"37","author":"K Peng","year":"2015","unstructured":"Peng K, Jin X, Liu S, Ji F. Effect of intraoperative dexmedetomidine on post-craniotomy pain. Clin Ther. 2015;37:1114\u201321.","journal-title":"Clin Ther"},{"key":"507_CR94","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1017\/S0265021505000669","volume":"22","author":"H Unlugenc","year":"2005","unstructured":"Unlugenc H, Gunduz M, Guler T, et al. The effect of pre-anaesthetic administration of intravenous dexmedetomidine on postoperative pain in patients receiving patient-controlled morphine. Eur J Anaesthesiol. 2005;22:386\u201391.","journal-title":"Eur J Anaesthesiol"},{"key":"507_CR95","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/ALN.0b013e31825681cb","volume":"116","author":"G Blaudszun","year":"2012","unstructured":"Blaudszun G, Lysakowski C, Elia N, Tram\u00e8r MR. Effect of perioperative systemic \u03b12 agonists on postoperative morphine consumption and pain intensity. Anesthesiology. 2012;116:1312\u201322.","journal-title":"Anesthesiology"},{"key":"507_CR96","first-page":"CD010358","volume":"2","author":"LJ Lundorf","year":"2016","unstructured":"Lundorf LJ, Nedergaard HK, M\u00f8ller AM. Perioperative dexmedetomidine for acute pain after abdominal surgery in adults. Cochrane Database Syst Rev. 2016;2:CD010358.","journal-title":"Cochrane Database Syst Rev"},{"key":"507_CR97","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0009-9236(99)80045-9","volume":"65","author":"FE Cunningham","year":"1999","unstructured":"Cunningham FE, Baughman VL, Tonkovich L, et al. Pharmacokinetics of dexmedetomidine (DEX) in patients with hepatic failure (HF). Clin Pharmacol Ther. 1999;65:128.","journal-title":"Clin Pharmacol Ther"},{"key":"507_CR98","unstructured":"European Medicines Agency. Dexdor H-C-2268-II-0003: EPAR, assessment report-variation. 2013. Available from: \n                        http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Assessment_Report_-_Variation\/human\/002268\/WC500140545.pdf\n                        \n                    . Accessed 28 Nov 2016."},{"key":"507_CR99","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1148\/radiol.13121232","volume":"267","author":"KP Mason","year":"2013","unstructured":"Mason KP, Robinson F, Fontaine P, Prescilla R. Dexmedetomidine offers an option for safe and effective sedation for nuclear medicine imaging in children. Radiology. 2013;267:911\u20137.","journal-title":"Radiology"},{"key":"507_CR100","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2165\/00003088-199936060-00005","volume":"36","author":"SN Wildt de","year":"1999","unstructured":"de Wildt SN, Kearns GL, Leeder JS, van den Anker JN. Glucuronidation in humans. Pharmacogenetic and developmental aspects. Clin Pharmacokinet. 1999;36:439\u201352.","journal-title":"Clin Pharmacokinet"},{"key":"507_CR101","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.50.2.259","volume":"50","author":"CP Strassburg","year":"2002","unstructured":"Strassburg CP, Strassburg A, Kneip S, et al. Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut. 2002;50:259\u201365.","journal-title":"Gut"},{"key":"507_CR102","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1124\/dmd.108.021709","volume":"36","author":"S Kaivosaari","year":"2008","unstructured":"Kaivosaari S, Toivonen P, Aitio O, et al. Regio- and stereospecific N-glucuronidation of medetomidine: the differences between UDP glucuronosyltransferase (UGT) 1A4 and UGT2B10 account for the complex kinetics of human liver microsomes. Drug Metab Dispos. 2008;36:1529\u201337.","journal-title":"Drug Metab Dispos"},{"key":"507_CR103","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","volume":"349","author":"GL Kearns","year":"2003","unstructured":"Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology: drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349:1157\u201367.","journal-title":"N Engl J Med"},{"issue":"276\u201382","key":"507_CR104","first-page":"e1","volume":"164","author":"C Chrysostomou","year":"2014","unstructured":"Chrysostomou C, Schulman SR, Herrera Castellanos M, et al. A phase II\/III, multicenter, safety, efficacy, and pharmacokinetic study of dexmedetomidine in preterm and term neonates. J Pediatr. 2014;164(276\u201382):e1\u20133.","journal-title":"J Pediatr"},{"key":"507_CR105","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jclinane.2006.08.011","volume":"19","author":"JC Finkel","year":"2007","unstructured":"Finkel JC, Quezado ZMN. Hypothermia-induced bradycardia in a neonate receiving dexmedetomidine. J Clin Anesth. 2007;19:290\u20132.","journal-title":"J Clin Anesth"},{"key":"507_CR106","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/206201b0","volume":"206","author":"MJ Dawkins","year":"1965","unstructured":"Dawkins MJ, Scopes JW. Non-shivering thermogenesis and brown adipose tissue in the human new-born infant. Nature. 1965;206:201\u20132.","journal-title":"Nature"},{"key":"507_CR107","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/00000542-199710000-00017","volume":"87","author":"P Talke","year":"1997","unstructured":"Talke P, Tayefeh F, Sessler DI, et al. Dexmedetomidine does not alter the sweating threshold, but comparably and linearly decreases the vasoconstriction and shivering thresholds. Anesthesiology. 1997;87:835\u201341.","journal-title":"Anesthesiology"},{"key":"507_CR108","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/00000542-199305000-00003","volume":"78","author":"JB Dyck","year":"1993","unstructured":"Dyck JB, Maze M, Haack C, et al. Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology. 1993;78:821\u20138.","journal-title":"Anesthesiology"},{"key":"507_CR109","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2253-15-17","volume":"15","author":"J Kim","year":"2015","unstructured":"Kim J, Kim W, Kim H-B, Kil H. Adequate sedation with single-dose dexmedetomidine in patients undergoing transurethral resection of the prostate with spinal anaesthesia: a dose\u2013response study by age group. BMC Anesthesiol. 2015;15:17.","journal-title":"BMC Anesthesiol"},{"key":"507_CR110","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4097\/kjae.2014.66.5.371","volume":"66","author":"SH Park","year":"2014","unstructured":"Park SH, Shin YD, Yu HJ, et al. Comparison of two dosing schedules of intravenous dexmedetomidine in elderly patients during spinal anesthesia. Korean J Anesthesiol. 2014;66:371.","journal-title":"Korean J Anesthesiol"},{"key":"507_CR111","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4097\/kjae.2015.68.6.575","volume":"68","author":"K-H Ko","year":"2015","unstructured":"Ko K-H, Jun I-J, Lee S, et al. Effective dose of dexmedetomidine to induce adequate sedation in elderly patients under spinal anesthesia. Korean J Anesthesiol. 2015;68:575.","journal-title":"Korean J Anesthesiol"},{"key":"507_CR112","first-page":"537","volume":"19","author":"HS Bakhamees","year":"2007","unstructured":"Bakhamees HS, El-Halafawy YM, El-Kerdawy HM, et al. Effects of dexmedetomidine in morbidly obese patients undergoing laparoscopic gastric bypass. Middle East J Anaesthesiol. 2007;19:537\u201351.","journal-title":"Middle East J Anaesthesiol"},{"key":"507_CR113","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1213\/ane.0b013e318172c47c","volume":"106","author":"B Tufanogullari","year":"2008","unstructured":"Tufanogullari B, White PF, Peixoto MP, et al. Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesth Analg. 2008;106:1741\u20138.","journal-title":"Anesth Analg"},{"key":"507_CR114","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jclinane.2005.05.009","volume":"18","author":"JM Feld","year":"2006","unstructured":"Feld JM, Hoffman WE, Stechert MM, et al. Fentanyl or dexmedetomidine combined with desflurane for bariatric surgery. J Clin Anesth. 2006;18:24\u20138.","journal-title":"J Clin Anesth"},{"key":"507_CR115","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1007\/s11605-007-0290-0","volume":"11","author":"C Dholakia","year":"2007","unstructured":"Dholakia C, Beverstein G, Garren M, et al. The impact of perioperative dexmedetomidine infusion on postoperative narcotic use and duration of stay after laparoscopic bariatric surgery. J Gastrointest Surg. 2007;11:1556\u20139.","journal-title":"J Gastrointest Surg"},{"issue":"5","key":"507_CR116","doi-asserted-by":"crossref","first-page":"e0128450","DOI":"10.1371\/journal.pone.0128450","volume":"10","author":"J Ni","year":"2015","unstructured":"Ni J, Wei J, Yao Y, et al. Effect of dexmedetomidine on preventing postoperative agitation in children: a meta-analysis. PLoS One. 2015;10(5):e0128450.","journal-title":"PLoS One"},{"key":"507_CR117","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12871-015-0127-4","volume":"15","author":"DJ Kim","year":"2015","unstructured":"Kim DJ, Kim SH, So KY, Jung KT. Effects of dexmedetomidine on smooth emergence from anaesthesia in elderly patients undergoing orthopaedic surgery. BMC Anesthesiol. 2015;15:139.","journal-title":"BMC Anesthesiol"},{"issue":"1313\u201315","key":"507_CR118","first-page":"e1","volume":"166","author":"E Mekitarian Filho","year":"2015","unstructured":"Mekitarian Filho E, Robinson F, de Carvalho WB, et al. Intranasal dexmedetomidine for sedation for pediatric computed tomography imaging. J Pediatr. 2015;166(1313\u201315):e1.","journal-title":"J Pediatr"},{"key":"507_CR119","doi-asserted-by":"crossref","first-page":"255","DOI":"10.17796\/jcpd.38.3.l828585807482966","volume":"38","author":"MN Surendar","year":"2014","unstructured":"Surendar MN, Pandey RK, Saksena AK, et al. A comparative evaluation of intranasal dexmedetomidine, midazolam and ketamine for their sedative and analgesic properties: a triple blind randomized study. J Clin Pediatr Dent. 2014;38:255\u201361.","journal-title":"J Clin Pediatr Dent"},{"key":"507_CR120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/pan.12287","volume":"24","author":"SA Sheta","year":"2014","unstructured":"Sheta SA, Al-Sarheed MA, Abdelhalim AA. Intranasal dexmedetomidine vs midazolam for premedication in children undergoing complete dental rehabilitation: a double-blinded randomized controlled trial. Paediatr Anaesth. 2014;24:181\u20139.","journal-title":"Paediatr Anaesth"},{"key":"507_CR121","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1365-2044.2012.07309.x","volume":"67","author":"VM Yuen","year":"2012","unstructured":"Yuen VM, Hui TW, Irwin MG, et al. A randomised comparison of two intranasal dexmedetomidine doses for premedication in children. Anaesthesia. 2012;67:1210\u20136.","journal-title":"Anaesthesia"},{"key":"507_CR122","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s40272-015-0145-1","volume":"17","author":"A Tug","year":"2015","unstructured":"Tug A, Hanci A, Turk HS, et al. Comparison of two different intranasal doses of dexmedetomidine in children for magnetic resonance imaging sedation. Paediatr Drugs. 2015;17:479\u201385.","journal-title":"Paediatr Drugs"},{"key":"507_CR123","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ijom.2013.02.003","volume":"42","author":"N Nooh","year":"2013","unstructured":"Nooh N, Sheta SA, Abdullah WA, Abdelhalim AA. Intranasal atomized dexmedetomidine for sedation during third molar extraction. Int J Oral Maxillofac Surg. 2013;42:857\u201362.","journal-title":"Int J Oral Maxillofac Surg"},{"key":"507_CR124","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/pan.12284","volume":"24","author":"S-S Wang","year":"2014","unstructured":"Wang S-S, Zhang M-Z, Sun Y, et al. The sedative effects and the attenuation of cardiovascular and arousal responses during anesthesia induction and intubation in pediatric patients: a randomized comparison between two different doses of preoperative intranasal dexmedetomidine. Paediatr Anaesth. 2014;24:275\u201381.","journal-title":"Paediatr Anaesth"},{"key":"507_CR125","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jclinane.2013.12.012","volume":"26","author":"Y Yao","year":"2014","unstructured":"Yao Y, Qian B, Chen Y, et al. Intranasal dexmedetomidine premedication reduces the minimum alveolar concentration of sevoflurane for tracheal intubation in children: a randomized trial. J Clin Anesth. 2014;26:309\u201314.","journal-title":"J Clin Anesth"},{"key":"507_CR126","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/pan.12574","volume":"25","author":"Y Yao","year":"2015","unstructured":"Yao Y, Qian B, Lin Y, et al. Intranasal dexmedetomidine premedication reduces minimum alveolar concentration of sevoflurane for laryngeal mask airway insertion and emergence delirium in children: a prospective, randomized, double-blind, placebo-controlled trial. Paediatr Anaesth. 2015;25:492\u20138.","journal-title":"Paediatr Anaesth"},{"key":"507_CR127","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.joms.2013.06.202","volume":"71","author":"X Zhang","year":"2013","unstructured":"Zhang X, Bai X, Zhang Q, et al. The safety and efficacy of intranasal dexmedetomidine during electrochemotherapy for facial vascular malformation: a double-blind, randomized clinical trial. J Oral Maxillofac Surg. 2013;71:1835\u201342.","journal-title":"J Oral Maxillofac Surg"},{"key":"507_CR128","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/AJP.0000000000000219","volume":"31","author":"K Peng","year":"2015","unstructured":"Peng K, Liu H-Y, Wu S-R, et al. Effects of combining dexmedetomidine and opioids for postoperative intravenous patient-controlled analgesia: a systematic review and meta-analysis. Clin J Pain. 2015;31:1097\u2013104.","journal-title":"Clin J Pain"},{"key":"507_CR129","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/ALN.0000000000000983","volume":"124","author":"FW Abdallah","year":"2016","unstructured":"Abdallah FW, Dwyer T, Chan VWS, et al. IV and perineural dexmedetomidine similarly prolong the duration of analgesia after interscalene brachial plexus block. Anesthesiology. 2016;124:683\u201395.","journal-title":"Anesthesiology"},{"key":"507_CR130","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/EJA.0b013e32832a2244","volume":"26","author":"K Rutkowska","year":"2009","unstructured":"Rutkowska K, Knapik P, Misiolek H. The effect of dexmedetomidine sedation on brachial plexus block in patients with end-stage renal disease. Eur J Anaesthesiol. 2009;26:851\u20135.","journal-title":"Eur J Anaesthesiol"},{"key":"507_CR131","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1213\/ANE.0b013e318290c566","volume":"117","author":"FW Abdallah","year":"2013","unstructured":"Abdallah FW, Abrishami A, Brull R. The facilitatory effects of intravenous dexmedetomidine on the duration of spinal anesthesia. Anesth Analg. 2013;117:271\u20138.","journal-title":"Anesth Analg"},{"key":"507_CR132","doi-asserted-by":"crossref","first-page":"e93114","DOI":"10.1371\/journal.pone.0093114","volume":"9","author":"H-H Wu","year":"2014","unstructured":"Wu H-H, Wang H-T, Jin J-J, et al. Does dexmedetomidine as a neuraxial adjuvant facilitate better anesthesia and analgesia? A systematic review and meta-analysis. PLoS One. 2014;9:e93114.","journal-title":"PLoS One"},{"key":"507_CR133","doi-asserted-by":"crossref","first-page":"R153","DOI":"10.1186\/cc10283","volume":"15","author":"J Gu","year":"2011","unstructured":"Gu J, Sun P, Zhao H, et al. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care. 2011;15:R153.","journal-title":"Crit Care"},{"key":"507_CR134","doi-asserted-by":"crossref","first-page":"e00045","DOI":"10.1002\/prp2.45","volume":"2","author":"J Lempi\u00e4inen","year":"2014","unstructured":"Lempi\u00e4inen J, Finckenberg P, Mervaala EE, et al. Dexmedetomidine preconditioning ameliorates kidney ischemia-reperfusion injury. Pharmacol Res Perspect. 2014;2:e00045.","journal-title":"Pharmacol Res Perspect"},{"key":"507_CR135","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/ALN.0b013e318164ca81","volume":"108","author":"S Dahmani","year":"2008","unstructured":"Dahmani S, Paris A, Jannier V, et al. Dexmedetomidine increases hippocampal phosphorylated extracellular signal-regulated protein kinase 1 and 2 content by an \u03b12-adrenoceptor-independent mechanism. Anesthesiology. 2008;108:457\u201366.","journal-title":"Anesthesiology"},{"key":"507_CR136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2012.11.047","volume":"1494","author":"Y-M Zhu","year":"2013","unstructured":"Zhu Y-M, Wang C-C, Chen L, et al. Both PI3K\/Akt and ERK1\/2 pathways participate in the protection by dexmedetomidine against transient focal cerebral ischemia\/reperfusion injury in rats. Brain Res. 2013;1494:1\u20138.","journal-title":"Brain Res"},{"key":"507_CR137","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.phrs.2015.11.004","volume":"103","author":"JA Riquelme","year":"2016","unstructured":"Riquelme JA, Westermeier F, Hall AR, et al. Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS\/NO dependent mechanism. Pharmacol Res. 2016;103:318\u201327.","journal-title":"Pharmacol Res"},{"key":"507_CR138","first-page":"25","volume":"8","author":"RD Sanders","year":"2007","unstructured":"Sanders RD, Maze M. Alpha2-adrenoceptor agonists. Curr Opin Investig Drugs. 2007;8:25\u201333.","journal-title":"Curr Opin Investig Drugs"},{"key":"507_CR139","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/ALN.0b013e31819daedd","volume":"110","author":"RD Sanders","year":"2009","unstructured":"Sanders RD, Xu J, Shu Y, et al. Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiology. 2009;110:1077\u201385.","journal-title":"Anesthesiology"},{"key":"507_CR140","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1213\/ane.0b013e3181733fdb","volume":"106","author":"RD Sanders","year":"2008","unstructured":"Sanders RD, Xu J, Shu Y, et al. General anesthetics induce apoptotic neurodegeneration in the neonatal rat spinal cord. Anesth Analg. 2008;106:1708\u201311.","journal-title":"Anesth Analg"},{"key":"507_CR141","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1213\/00000539-200302000-00041","volume":"96","author":"K Engelhard","year":"2003","unstructured":"Engelhard K, Werner C, Ebersp\u00e4cher E, et al. The effect of the alpha 2-agonist dexmedetomidine and the N-methyl-d-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg. 2003;96:524\u201331.","journal-title":"Anesth Analg"},{"key":"507_CR142","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000542-199609000-00014","volume":"85","author":"P Talke","year":"1996","unstructured":"Talke P, Bickler PE. Effects of dexmedetomidine on hypoxia-evoked glutamate release and glutamate receptor activity in hippocampal slices. Anesthesiology. 1996;85:551\u20137.","journal-title":"Anesthesiology"},{"key":"507_CR143","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/00000542-199809000-00005","volume":"89","author":"H Scheinin","year":"1998","unstructured":"Scheinin H, Aantaa R, Anttila M, et al. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers. Anesthesiology. 1998;89:574\u201384.","journal-title":"Anesthesiology"},{"key":"507_CR144","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2125.1990.tb03748.x","volume":"30","author":"S Karhuvaara","year":"1990","unstructured":"Karhuvaara S, Kallio A, Scheinin M, et al. Pharmacological effects and pharmacokinetics of atipamezole, a novel alpha 2-adrenoceptor antagonist: a randomized, double-blind cross-over study in healthy male volunteers. Br J Clin Pharmacol. 1990;30:97\u2013106.","journal-title":"Br J Clin Pharmacol"},{"key":"507_CR145","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1365-2125.1991.tb05505.x","volume":"31","author":"S Karhuvaara","year":"1991","unstructured":"Karhuvaara S, Kallio A, Salonen M, et al. Rapid reversal of alpha 2-adrenoceptor agonist effects by atipamezole in human volunteers. Br J Clin Pharmacol. 1991;31:160\u20135.","journal-title":"Br J Clin Pharmacol"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40262-017-0507-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-017-0507-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-017-0507-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T03:28:17Z","timestamp":1500089297000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40262-017-0507-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,19]]},"references-count":145,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["507"],"URL":"https:\/\/doi.org\/10.1007\/s40262-017-0507-7","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,19]]}}}